Top Tweets for #DefendYourHealth
Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses #DefendYourHealth #SNGX https://t.co/X1F2zwj6EV
Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference #defendyourhealth $SNGX https://t.co/pWAiXMCoPe
Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease $SNGX #DefendYourHealth
https://t.co/HojXEaTrib
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma #CTCL #DefendYourHealth #clinicaltrials https://t.co/V4dIEaPYER
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease #DefendYourHealth https://t.co/KE2nAMluVG
Strong Clinical Support for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; Exclusive Interview with Dr. Brian Poligone https://t.co/pZLTsjAHsJ #DefendYourHealth #CTCL #ClinicalTrials
Q&A with Dr. Ellen Kim, the Lead Principal Investigator for Soligenix’s Phase 3 FLASH study in CTCL:
Soligenix's Hybryte: Lighting the Way Towards Commercial Success with Promising Flash Study Results https://t.co/kqA9KLZt5T
#Hybryte #DefendYourHealth #biotech #clinicaltrials
Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma
https://t.co/PIaAAuLFdU
#ctcl #positiveclinicalresults #defendyourhealth #biotech #clinicalstudy $sngx
Learn more about Soligenix! #defendyourhealth #ctcl #psoriasis #biotech #sngx https://t.co/OegyUAdjz5
Discover the mission of Soligenix in this exclusive interview with CEO Dr. Christopher Schaber #defendyourhealth #biotech https://t.co/t0tN94nrob
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
Clinical Success Achieved in Second Cohort of Patients
#SNGX #psoriasis #DefendYourHealth #ClinicalTrials
https://t.co/gqxp9fTr8y
"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery #defendyourhealth #ctcl #raredisease
https://t.co/xBa1602GHy
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease https://t.co/OHSCgiMNay
#defendyourhealth #BehçetsDisease #RareDisease
Soligenix’s President & CEO, Dr. Christopher Schaber has made @medicine_maker Power List 2023 #raredisease #smallmoleclue #defendyourhealth
https://t.co/C8wT6rhKVd
Soligenix Announces Scheduling of Type A Meeting with the U.S. FDA to Review Proposed Study Design for a Second Phase 3 Study Evaluating HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma #ctcl #defendyourhealth #raredisease https://t.co/47vYx4oUVg
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma #ctcl #defendyourhealth #raredisease https://t.co/jUspBRz5l0
Soligenix Announces Appointment of Timothy R. Coté, M.D. to its Board of Directors #defendyourhealth #raredisease https://t.co/GNQ6JxtQlF
Soligenix Enters into Exclusive Option Agreement with Silk Road Therapeutics for Rights to Topical Pentoxifylline Designed to Treat Behçet's Disease #defendyourhealth #raredisease https://t.co/WVbhztSvoW
Soligenix Submits Type A Meeting Request to U.S. FDA to Review Proposed Study Design for a Second Phase 3 Study Evaluating HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma #ctcl #defendyourhealth https://t.co/P4zMifUdLv
Soligenix Receives USAN Approval for "Hypericin Sodium" as Nonproprietary Name for Novel Active Ingredient in HyBryte™ and SGX302 #ctcl #defendyourhealth https://t.co/Smgg0NrZ2P
Last Seen Hashtags on Sotwe
ジムエグザム
Seen from United States
omegle
Seen from United States
omegle() filter:videos
Seen from United States
momsonn
Seen from India
alanyat̑ȓ̈avȇ̈ſti
Seen from Turkey
ebony #squirt
Seen from United States
Black #girl
Seen from India
bnwo edits
Seen from Canada
白雪美月
Seen from Thailand
omegle()************************filter:videos
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113.8M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.6M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.7M followers
KATY PERRY
@katyperry
89.6M followers
Taylor Swift
@taylorswift13
83.5M followers
Lady Gaga
@ladygaga
75M followers
Virat Kohli
@imvkohli
72.8M followers
Kim Kardashian
@kimkardashian
70.7M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65.7M followers
Bill Gates
@billgates
64.9M followers
Selena Gomez
@selenagomez
62.7M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers